ALYATEC begins the TT-07 clinical study in October 2026.
The study is intended for adolescents aged 12 to 17 who are allergic to birch pollen. Its aim is to evaluate the efficacy of a desensitization treatment in tablet form.
You can find all the information about the study and how to participate on the dedicated webpage.
Feel free to spread the word about this study and receive €50 through our referral program!
See you soon at ALYATEC!
